Replies to post #63928 on NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Ok. Maybe there was only 1 phase 2. I thought there were 2 parts to it, the second including some changes. That the first was unblinded at the end, but the second remained blinded and was pulled into the Phase 3.

The issue is the FDA forcing crossover. If the reason they forced crossover in the phase 3 was because such existed in the phase 2 (that NWBO wanted to include in the phase 3)... then I have been off base to be so upset about that issue. That would be totally understandable of the FDA.

You are saying that Phase 2 did have crossover. Did the FDA insist on it in the Phase 2? Seems unlikely.